Loading stock data…
Regentis Biomaterials Ltd (RGNT)
$3.77-0.13 (-3.33%)
Market ClosedLast close Jun 29
Regentis Biomaterials Ltd., a regenerative medicine company, develops and commercializes tissue repair solutions in the United States.
Historical Price
Price (Candle)
Synthesizing Whystock Narrative...
Quarterly Financials
| Metric (USD) | Q4 2025 | Q2 2025 | Q4 2024 | Q2 2024 |
|---|---|---|---|---|
| Total Revenue | — | — | — | — |
| Gross Profit | — | — | — | — |
| Operating Income | — | — | — | — |
| Net Income | — | — | — | — |
Peer Comparison
JNJUNHPFE
Fundamentals
Regentis Biomaterials Ltd., a regenerative medicine company, develops and commercializes tissue repair solutions in the United States. It offers Gelrin, a platform based on hydrogel matrix of polyethylene glycol diacrylate and denatured fibrinogen fo...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$36.51M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
-
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
-
Volume
Today's trading volume
176,966
Recent News
This Monthly Dividend Powerhouse Is Trading at a Bargain-Bin Valuation
EPR Properties offers income investors a rare combination: a 6.3% monthly dividend yield, a conservative 73% payout ratio, and diversified exposure to experiential real estate well beyond movie theatres, trading at just 10.7x FFO.
Why Did RGNT Stock Surge More Than 850% Today?
Regentis Biomaterials filed a notice to withdraw its Form F-1 registration statement, indicating that it did not wish to proceed with a proposed public offering announced last month.
Regentis Biomaterials (RGNT) Appoints New CFO/CBO as GelrinC Nears Commercial Launch
Regentis Biomaterials Ltd. (NYSEAMERICAN:RGNT) is one of the best up and coming penny stocks to buy. On February 4, Regentis Biomaterials appointed Ori Gon as Chief Financial Officer and Chief Business Officer to lead the company’s financial strategy and commercial development. Gon joined the regenerative medicine firm as its lead product, GelrinC, nears commercial launch […]
Sector Update: Health Care Stocks Slide Late Afternoon
Health care stocks declined late Thursday afternoon, with the NYSE Health Care Index and the Health
Sector Update: Health Care Stocks Softer in Afternoon Trading
Health care stocks declined Thursday afternoon with the NYSE Health Care Index dropping 0.5% and the